BeiGene gets FDA approval for Brukinsa to treat Waldenström’s macroglobulinemia
The US FDA approval of Brukinsa was based on results from the Phase 3 ASPEN trial, which evaluated…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Sep 21
The US FDA approval of Brukinsa was based on results from the Phase 3 ASPEN trial, which evaluated…
01 Sep 21
The Phase 3 clinical trial will evaluate SK’s vaccine candidate GBP510 against the AstraZeneca/Oxford Covid-19 vaccine
01 Sep 21
The collaboration aims to identify eligible patients across England and treat them using Leqvio through a population health…
30 Aug 21
The EC approval is based on data from the vosoritide clinical development programme, including results from the Phase…
27 Aug 21
A focus on how crucial mobile apps in clinical trials are in the wider landscape of emerging digital…
27 Aug 21
The drug was already approved in the US and the European Union for the treatment of CKD in…
27 Aug 21
The court ruled that certain parts of the patent were invalid and that the earlier jury verdict was…
26 Aug 21
The collaboration will leverage Lycia's LYTAC platform to discover and develop novel degraders for up to five targets…
26 Aug 21
According to the Phase 3 data, a booster dose of Comirnaty elicited significant immune responses, with a favourable…
25 Aug 21
Shape Therapeutics will use its RNA editing platform RNAfix and AAVid platform for the development of gene therapies…